Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Leadership & People

Set Alert for Leadership & People

Astellas’s US Commercial Head Petroutsas On New Launches

The Japanese pharma’s new US commercial head Michael Petroutsas talked to Scrip about the launches of Veozah and Izervay.

Launches Leadership

Executives On The Move: Assertio Holdings Acquires Chief Executive Officer from Glenmark Pharmaceuticals

Recent moves in the industry include changes at the top for Inhibrx and Monte Rosa Therapeutics, plus Imunon, Avrobio and Kronos Bio acquire chief financial officers from Cyteir Therapeutics, Oyster Point Pharma and Senti Biosciences, respectively.

Leadership Executive Changes

Amid Talk Of KKR Stake Sale, JB CEO Stresses Business As Usual

In an interview with JB CEO Nikhil Chopra, Scrip discusses talk of a stake sale by private equity fund KKR, gains from acquisitions including select Novartis brands, plans to ascend to the top five in cardiology and a ramp up of the CDMO business, which has clients including J&J.

Commercial Business Strategies

Executives On The Move: Eight New C-Suite Appointments Among This Week's Changes

Recent moves in the industry include C-suite shuffles at Cosmo Pharmaceuticals and Nurix Therapeutics, as Cosmo Pharmaceuticals gets a new chief executive officer.

Leadership Executive Changes

Executives On The Move: Ocular Therapeutix Hooks ChIef Medical Officer From Beacon

Recent moves in the industry include C-suite shuffle at Senti Biosciences, plus BioMarin Pharmaceutical gets new chief commercial officer.

Leadership Executive Changes

AstraZeneca Targets $80bn Sales By 2030 But Analysts Still To Be Convinced

The UK company has unveiled a new strategy for 2030 and beyond but analysts' forecasts fall around $15bn short of the company’s own projections.

Commercial Clinical Trials

Executives On The Move: Viracta Therapeutics Acquires Chief Fincancial Officer From Harpoon

Recent moves in the industry include new chief scientific officer at Wave Life Sciences, while Alliance Pharma gets a new CEO.

Executive Changes Leadership

Bayer Revels In Its Football Club's Remarkable Run

The German group has spent much of the year reviewing the pros and cons of its hybrid structure but there was never any question about divesting Bayer 04 Leverkusen, its extremely successful football team, CEO Bill Anderson told journalists.

Leadership Companies

Executives On The Move: Senior Moves At ALX Oncology, Aprea And PDS

Recent moves in the industry include new CEOs at Juno Pharmaceuticals and YS Biopharma, plus Glenmark gets a new chief communications officer.

Leadership Executive Changes

Pfizer Recruits Industry Analyst Baum To Advance Corporate Strategy

Longtime pharmaceutical industry analyst Andrew Baum will join Pfizer’s executive leadership team.

Leadership Companies

Executives On The Move: Senior Moves At Innovent Biologics, Actym Therapeutics And Enanta Pharmaceuticals

Recent moves in the industry also include C-suite shuffles at Faron Pharmaceuticals and new chief financial officers at Orion, BioVaxys Technology and Cullinan Therapeutics.

Executive Changes Leadership

‘It’s Not About Me’ – AstraZeneca’s Soriot Says His Pay Rise Will Help European Pharma

AstraZeneca’s CEO says his potential 11% pay rise is needed to help the European industry remain competitive with its higher paying US counterparts.

Commercial Sales & Earnings
See All